HC Wainwright&Co.:重申Avalo Therapeutics(AVTX.US)评级,由中性调整至中性评级。Avalo Therapeutics(AVTX.US)公司简介:Avalo Therapeutics Inc是一家临床阶段生物技术公司,专注于免疫失调的治疗。该公司的主要资产是AVTX-009,一种针对炎症性疾病的抗IL-1B单克隆抗体(“mAb”)。Avalo的产品线还包括...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.